Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramucirumab with Irinotecan and Cetuximab in Advanced Colorectal Cancer
NCT01079780Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jan 2011
- Primary completion
- Feb 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ramucirumab in colorectal cancer (CRC), sponsored by Eastern Cooperative Oncology Group. Started Jan 2011; status: completed.
02
Drugs
ramucirumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01079780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079780.